Founded in 2004, ModiQuest Research is one of the leading custom antibody generation and development providers.
ModiQuest specializes in the generation of monoclonal antibodies against difficult target antigens for R&D, diagnostic and therapeutic applications. Using its proprietary ModiFuse™ (hybridoma electrofusion), ModiSelect™ (B-cell selection) and ModiPhage™ (phage display) technologies, ModiQuest can generate very large panels of monoclonal antibodies from various backgrounds such as mouse, rat, rabbit, chicken, llama and human, as well as transgenic animals harboring the human immunoglobulin (antibody) gene repertoire, against virtually any target. Besides antibody lead generation, ModiQuest also provides extensive antibody development and optimization procedures, such as affinity maturation, humanization, stable cell line generation and antibody production in transient and stable mammalian cell systems.
To date, ModiQuest has successfully completed over 250 antibody generation and development projects for clients in Europe, the US, Asia and Russia. Typically, we run over 25 different client projects per year with a maximum of 10 projects at any given time.
The ModiQuest team consists of highly skilled and experienced scientists and professionals, fully dedicated and focused on the successful execution and completion of client projects. In addition, the team is constantly working on optimizing and expanding our technology platform to ensure a unique and high-quality services and product offering.
ModiQuest is based in Oss, The Netherlands, close to the German and Belgian border. We are located in the state-of-art facilities of a dedicated life science park (called the Pivot Park).